An Unusual Adverse Effect of Interferon: Hypertrichosis of the Eyelashes
- 1 July 2000
- journal article
- case report
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 20 (7) , 633-634
Abstract
Hypertrichosis of the eyelashes is a rare adverse effect of interferon-α treatment. We present a 21-year-old man with chronic renal failure and hepatitis B virus (HBV) infection who developed hypertrichosis of the eyelashes as a complication of IFN-α therapy. The patient was a candidate for living related renal transplantation and was given IFN-α 15 million units per week for HBV DNA positivity. After 6 months of therapy, HBV DNA positivity persisted, and the dose of IFN was increased to 30 million units per week. At the end of the first half of the second 6 months of therapy, the patient suffered from bilateral hypertrichosis of the eyelashes.Keywords
This publication has 12 references indexed in Scilit:
- CHRONIC VIRAL HEPATITIS IN RENAL TRANSPLANT RECIPIENTS WITH ALLOGRAFTS FUNCTIONING FOR MORE THAN 20 YEARS1,2Transplantation, 1999
- Long-Term Outcome of Renal Transplantation in Hepatitis B Surface Antigen-Positive Patients in Cyclosporin EraAmerican Journal of Nephrology, 1997
- High dose interferon treatment in chronic hepatitis C.Gut, 1993
- Telogen Effluvium due to Recombinant Interferon α-2bDermatology, 1992
- Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?The Lancet, 1990
- Hypertrichosis of the Eyelashes Associated With Interferon-a Therapy for Chronic Granulocytic LeukemiaSouthern Medical Journal, 1990
- The biological basis for clinical use of interferonJournal of Hepatology, 1990
- Side Effects of Alpha InterferonSeminars in Liver Disease, 1989
- INTERFERONS AS MEDIATORS OF PSYCHIATRIC MORBIDITYThe Lancet, 1987
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984